Dr James H. Sabry

Personal Data
Nationality: Canadian and American
Year of Birth: 1958
Position
Global Head of Pharma Partnering
Studies
- M.D. - Queen’s University, 1983 (Kingston, Canada)
- M.Sc. - California Institute of Technology, Biology, 1989 (Pasadena, USA)
- Ph.D. - University of California, San Francisco, Neuroscience, 1994 (San Francisco, USA)
- Postdoctoral fellow - Stanford University, Biochemistry, 1994-1998 (Stanford, USA)
Professional Career
- 1984-1987
Harvard Medical School (Boston, USA), Resident in Neurology - 1987
Harvard Medical School (Boston, USA), Chief Resident in Neurology - 1989-1998
University of California, San Francisco (San Francisco, USA), Adjunct Clinical Appointment in the Department of Neurology - 1997-2006
Co-founder, President and CEO of Cytokinetics - 2008-2010
President and CEO of Arete Therapeutics - 2010-2013
Global Head and Vice President of Genentech Partnering, USA - 2013-2018
Global Head and Senior Vice President of Genentech Partnering, USA - 2018
Global Head of Pharma Partnering, Roche Basel, Switzerland
Other Activities / Memberships
- since 1998
Member of Scientific Advisory Board at Cytokinetics - 2007-2008
Executive Chairman of the Board of Directors of Cytokinetics - 2008-2010
Chairman of the Board of Directors of Cytokinetics - 2005-2016
Member of the Board of Directors of HopeLab - 2015-2016
Member of the Board of Directors of California Life Sciences Association - 2016-2020
Member of the Board of Directors of Coalition for the Life Sciences
Board Memberships in listed companies
- since April 2019
Member of the Board of Directors of Chugai Pharmaceutical Co., Ltd.